These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7200429)

  • 21. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats.
    Castelló ME; Bolioli B; Dajas F
    Pharmacol Biochem Behav; 1992 Mar; 41(3):547-50. PubMed ID: 1584833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of neurotransmitters or drugs on the in vivo release of dopamine and its metabolites.
    Kito S; Shimoyama M; Arakawa R
    Jpn J Pharmacol; 1986 Jan; 40(1):57-67. PubMed ID: 2870204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and behavioural indices of striatal dopaminergic activity after 6-methyltetrahydropterin.
    Olgiati VR; Algeri S; Stramentinoli G
    Pharmacol Res Commun; 1987 Mar; 19(3):231-40. PubMed ID: 3602044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of dopamine-containing amacrine cells of retina: light-induced increase of acidic dopamine metabolites.
    Cohen J; Hadjiconstantinou M; Neff NH
    Brain Res; 1983 Jan; 260(1):125-7. PubMed ID: 6297678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choline and physostigmine enhance haloperidol-induced HVA and DOPAC accumulation.
    Millington WR; Wurtman RJ
    Eur J Pharmacol; 1982 Jun; 80(4):431-4. PubMed ID: 7106193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
    Nowak K; Welsch-Kunze S; Kuschinsky K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):385-91. PubMed ID: 3405313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
    Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration.
    Scatton B
    Eur J Pharmacol; 1977 Dec; 46(4):363-9. PubMed ID: 590344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats.
    Ibii N; Ikeda M; Takahara Y; Eigyo M; Akiyoshi T; Matsushita A
    Peptides; 1989; 10(4):779-83. PubMed ID: 2587420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.
    Imazu Y; Kobayashi K; Shohmori T
    Neurochem Res; 1989 May; 14(5):459-64. PubMed ID: 2747836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J; Coviella IL; Wurtman RJ
    Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished catalepsy and dopamine metabolism distinguish aripiprazole from haloperidol or risperidone.
    Nakai S; Hirose T; Uwahodo Y; Imaoka T; Okazaki H; Miwa T; Nakai M; Yamada S; Dunn B; Burris KD; Molinoff PB; Tottori K; Altar CA; Kikuchi T
    Eur J Pharmacol; 2003 Jul; 472(1-2):89-97. PubMed ID: 12860477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.